Results 111 to 120 of about 34,537 (182)

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. [PDF]

Open Forum Infect Dis
Post FA, Wohl D, Liegeon G, Brar I, Hagins D, Yazdanpanah Y, Avihingsanon A, Liu H, Aizen K, Hindman JT, Gupta S.   +10 more
europepmc   +1 more source

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin. [PDF]

Clin Infect Dis
Osuala EC, Nkuhairwe IN, Letsoalo MP, Naidoo K, Perumal R, Rooney JF, Wiesner L, Wasmann RE, Denti P, Dooley KE, Naidoo A, INSIGHT Study Team.   +11 more
europepmc   +1 more source

The multifaceted antiretroviral coverage provided by BIC/FTC/TAF: a pharmacokinetic/pharmacodynamic revisitation. [PDF]

Infez Med
Di Perri G, Calcagno A.
europepmc   +1 more source

Use of dual ART in individuals with different HBV serological patterns. [PDF]

Curr Opin HIV AIDS
Swaine T, Bhagani S.
europepmc   +1 more source

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply [PDF]

Clinical and Molecular Hepatology
Hyeyeon Hong, Jonggi Choi
doaj   +1 more source

Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study. [PDF]

J Korean Med Sci
Lim J, Yang J, Kim YJ, Kim HJ, Choi J.
europepmc   +1 more source

HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort. [PDF]

Infect Dis Ther
Foncillas A, De La Mora L, Berrocal L, de Lazzari E, Calvo J, Sempere A, Chivite I, Inciarte A, Martínez-Rebollar M, Torres B, González-Cordón A, Blanco JL, Miró JM, Martínez E, Laguno M, Mallolas J, Ambrosioni J.   +16 more
europepmc   +1 more source

Real-world identification of high-risk medications for drug-induced osteoporosis: a multi-method pharmacovigilance study based on FAERS with WHO Vigibase validation. [PDF]

Front Endocrinol (Lausanne)
Gao W, Tan E, Zhu J, Liu W, Sun J, Su Z.
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source

Toxicity of the Antiretrovirals Lamivudine, Dolutegravir, and Tenofovir on the Microalga <i>Chlorella vulgaris</i>. [PDF]

ACS Omega
Souza-Silva G, Alcantara M, Moreira C, Starling MC, Souza C, Nunes K, Pereira C, Mol M, Silveira M.   +8 more
europepmc   +1 more source